TY - JOUR
T1 - Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects
AU - Kimura, Hirokazu
AU - Konno, Satoshi
AU - Makita, Hironi
AU - Taniguchi, Natsuko
AU - Kimura, Hiroki
AU - Goudarzi, Houman
AU - Shimizu, Kaoruko
AU - Suzuki, Masaru
AU - Shijubo, Noriharu
AU - Shigehara, Katsunori
AU - Ono, Junya
AU - Izuhara, Kenji
AU - Ito, Yoichi Minagawa
AU - Nishimura, Masaharu
N1 - Publisher Copyright:
© 2018 Japanese Society of Allergology
PY - 2018/7
Y1 - 2018/7
N2 - Background: Many studies have attempted to clarify the factors associated with serum periostin levels in asthmatic patients. However, these results were based on studies of subjects mainly characterized by high eosinophil counts, which may present as an obstacle for clarification in the identification of other factors associated with serum periostin levels. The aim of this study was to determine the factors associated with serum periostin levels in healthy subjects. We also assessed some factors in asthmatic subjects to confirm their extrapolation for management of asthma. Methods: Serum periostin levels were measured in 230 healthy subjects. Clinical factors of interest included body mass index (BMI) and allergic rhinitis (AR). Additionally, we confirmed whether these factors were associated with serum periostin in 206 asthmatic subjects. We further evaluated several obesity-related parameters, such as abdominal fat distribution and adipocytokine levels. Results: Smoking status, blood eosinophil count, total immunoglobulin E, and the presence of AR were associated with serum periostin in healthy subjects. There was a negative association between BMI and serum periostin in both healthy and asthmatic subjects, while there was a tendency of a positive association with AR in asthmatic subjects. There were no differential associations observed for subcutaneous and abdominal fat in relation to serum periostin in asthmatic subjects. Serum periostin was significantly associated with serum levels of adiponectin, but not with leptin. Conclusions: Our results provided clarity as to the factors associated with serum periostin levels, which could be helpful in the interpretation of serum periostin levels in clinical practice.
AB - Background: Many studies have attempted to clarify the factors associated with serum periostin levels in asthmatic patients. However, these results were based on studies of subjects mainly characterized by high eosinophil counts, which may present as an obstacle for clarification in the identification of other factors associated with serum periostin levels. The aim of this study was to determine the factors associated with serum periostin levels in healthy subjects. We also assessed some factors in asthmatic subjects to confirm their extrapolation for management of asthma. Methods: Serum periostin levels were measured in 230 healthy subjects. Clinical factors of interest included body mass index (BMI) and allergic rhinitis (AR). Additionally, we confirmed whether these factors were associated with serum periostin in 206 asthmatic subjects. We further evaluated several obesity-related parameters, such as abdominal fat distribution and adipocytokine levels. Results: Smoking status, blood eosinophil count, total immunoglobulin E, and the presence of AR were associated with serum periostin in healthy subjects. There was a negative association between BMI and serum periostin in both healthy and asthmatic subjects, while there was a tendency of a positive association with AR in asthmatic subjects. There were no differential associations observed for subcutaneous and abdominal fat in relation to serum periostin in asthmatic subjects. Serum periostin was significantly associated with serum levels of adiponectin, but not with leptin. Conclusions: Our results provided clarity as to the factors associated with serum periostin levels, which could be helpful in the interpretation of serum periostin levels in clinical practice.
KW - Asthma
KW - Healthy subjects
KW - Obesity
KW - Periostin
KW - Rhinitis
UR - http://www.scopus.com/inward/record.url?scp=85044674388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044674388&partnerID=8YFLogxK
U2 - 10.1016/j.alit.2017.11.006
DO - 10.1016/j.alit.2017.11.006
M3 - Article
C2 - 29223720
AN - SCOPUS:85044674388
SN - 1323-8930
VL - 67
SP - 357
EP - 363
JO - Allergology International
JF - Allergology International
IS - 3
ER -